A phase 2 extension study of MVA-BN-RSV Vaccine
Latest Information Update: 25 Jul 2023
At a glance
- Drugs MVA-BN RSV (Primary)
- Indications Respiratory syncytial virus infections
- Focus Therapeutic Use
- 22 Jul 2023 Status changed from recruiting to discontinued according to Bavarian Nordic media release.
- 08 Aug 2018 Results published in the Media Release
- 24 May 2018 According to a Bavarian Nordic media release, results from this study are expected in H1, 2018.